Deborah Knobelman - Net Worth and Insider Trading

Deborah Knobelman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deborah Knobelman owns 1 companies in total, including Senti Biosciences Inc (SNTI) .

Click here to see the complete history of Deborah Knobelman’s form 4 insider trades.

Insider Ownership Summary of Deborah Knobelman

Ticker Comapny Transaction Date Type of Owner
SNTI Senti Biosciences Inc 2022-06-08 Chief Financial Officer

Deborah Knobelman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deborah Knobelman Ownership Network

Ownership Network List of Deborah Knobelman

No Data

Ownership Network Relation of Deborah Knobelman

Insider Network Chart

Deborah Knobelman Owned Company Details

What does Senti Biosciences Inc do?

Who are the key executives at Senti Biosciences Inc?

Deborah Knobelman is the Chief Financial Officer of Senti Biosciences Inc. Other key executives at Senti Biosciences Inc include Chief Medical & Devt. Officer Kanya Rajangam , 10 percent owner Scott D Sandell , and 10 percent owner Bayer Us Holding Lp .

Senti Biosciences Inc (SNTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Senti Biosciences Inc (SNTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senti Biosciences Inc (SNTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Senti Biosciences Inc (SNTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Senti Biosciences Inc Insider Transactions

No Available Data

Deborah Knobelman Mailing Address

Above is the net worth, insider trading, and ownership report for Deborah Knobelman. You might contact Deborah Knobelman via mailing address: C/o Senti Biosciences, Inc., 2 Corporate Drive First Floor, South San Francisco Ca 94080.

Discussions on Deborah Knobelman

No discussions yet.